December 21, 2015/Cancer

Multidisciplinary Adrenal Clinic

There when you—and your patients—need us

Pre-opCT_650x450

By Eren Berber, MD, and Georgiana Dobri, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cleveland Clinic’s Endocrinology & Metabolism Institute offers a Multidisciplinary Adrenal Clinic that evaluates about 300 patients with adrenal disorders every year. Patients presenting at the Multidisciplinary Adrenal Clinic receive a workup of their adrenal tumors based on guidelines from the National Institutes of Health and the American Association of Clinical Endocrinologists/American Association of Endocrine Surgeons.

The center holds monthly Multidisciplinary Tumor Boards, where complex adrenal cases are discussed and treatment plans are developed. The Endocrine Surgery Department performs 40 to 50 adrenalectomies every year.

Multidisciplinary expertise

Some of the experts within the Adrenal Clinic from various disciplines include:

  • Eren Berber, MD, Director — from Endocrine Surgery
  • Georgiana Dobri, MD, from Endocrinology
  • Erick Remer, MD, from Diagnostic Radiology
  • Charis Eng, MD, PhD, from the Genomic Medicine Institute
  • Donald Neumann, MD, PhD, from Nuclear Medicine
  • Brian Rini, MD, from Oncology

Case study

This patient case illustrates the accessibility of Cleveland Clinic’s adrenal disease experts, as well as the quality of our care based on a multidisciplinary approach:

A 50-year-old woman who was working overseas for the U.S. government presented at a hospital in Germany in hypertensive crisis. Imaging was performed and the patient was found to have a 4-cm right adrenal mass.

The treating physician contacted Dr. Berber seeking his expertise in adrenal disorders. Dr. Berber coordinated the appropriate workup, which included checking serum and 24-hour urine collections for catecholamines and metanephrines. The patient’s catecholamines and metanephrines were four-fold elevated.

Advertisement

The Cleveland Clinic Endocrine Surgery team stayed in communication with the physicians in Germany and the patient was started on alpha blockade with phenoxybenzamine, which stabilized her blood pressure.

Arrangements were made for her to have a minimally invasive adrenalectomy at Cleveland Clinic. Three weeks later, the patient traveled to Cleveland Clinic. The details of the operation were discussed with her, and she provided consent for a robotic adrenalectomy. The surgery was performed uneventfully.

The patient stayed one day in the hospital. She was discharged and at two-week followup, she was recovering well and did not have any complications. Plasma catecholamine and metanephrine levels at one month were normal, suggesting the patient was cured.

Figure 1. Preoperative CT scan demonstrating the right-sided pheochromocytoma.

Pre-opCT_650x450

Figure 2. Intraoperative photo showing the dissection of the adrenal mass during robotic adrenalectomy.

Advertisement

inset_2

Dr. Berber is Director of the Multidisciplinary Adrenal Clinic and Director of Robotic Endocrine Surgery in the Department of Endocrine Surgery. Dr. Dobri is an endocrinologist in the Department of Endocrinology, Diabetes and Metabolism, with a special interest in adrenal and pituitary disease. For more information contact Dr. Berber at berbere@ccf.org or 216.445.0555, or Dr. Dobri at dobrig@ccf.org or 216.636.5554.

Related Articles

Women's health physician
April 16, 2024/Cancer
Watching Out for Primary Ovarian Insufficiency

An underdiagnosed condition in patients with cancer

Fluorescent imaging during small bowel surgery
April 11, 2024/Cancer/Surgical Oncology
Fluorescence Imaging Augments Surgical Inspection and Palpation for Small Bowel Carcinoid Tumors

Study demonstrates superior visualization of occult primary lesions

microwave ablation of liver tumor
150-Watt, Single-Antenna Microwave Ablation System Demonstrates Safety and Efficacy

New device offers greater tumor control for malignant liver lesions

viral-induced cancer
April 3, 2024/Cancer
Mechanism of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) May Serve as Clue to More Effective Treatment

Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer

Dr. Mukherjee at Cleveland Clinic
April 1, 2024/Cancer/Blood Cancers
Many Patients with “Indolent” Systemic Mastocytosis Experience Rapid Decline and Lower Survival

First-ever U.S. population-level retrospective analysis reveals many patients with systemic mastocytosis need faster intervention

Cleveland Clinic physiatrist
March 22, 2024/Cancer/Innovations
The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Ad